<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38325873</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>384</Volume><PubDate><Year>2024</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial.</ArticleTitle><Pagination><StartPage>e076506</StartPage><MedlinePgn>e076506</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e076506</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj-2023-076506</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate whether a structured online supervised group physical and mental health rehabilitation programme can improve health related quality of life compared with usual care in adults with post-covid-19 condition (long covid).</AbstractText><AbstractText Label="DESIGN">Pragmatic, multicentre, parallel group, superiority randomised controlled trial.</AbstractText><AbstractText Label="SETTING">England and Wales, with home based interventions delivered remotely online from a single trial hub.</AbstractText><AbstractText Label="PARTICIPANTS">585 adults (26-86 years) discharged from NHS hospitals at least three months previously after covid-19 and with ongoing physical and/or mental health sequelae (post-covid-19 condition), randomised (1:1.03) to receive the Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) intervention (n=298) or usual care (n=287).</AbstractText><AbstractText Label="INTERVENTIONS">Best practice usual care was a single online session of advice and support with a trained practitioner. The REGAIN intervention was delivered online over eight weeks and consisted of weekly home based, live, supervised, group exercise and psychological support sessions.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome was health related quality of life using the patient reported outcomes measurement information system (PROMIS) preference (PROPr) score at three months. Secondary outcomes, measured at three, six, and 12 months, included PROMIS subscores (depression, fatigue, sleep disturbance, pain interference, physical function, social roles/activities, and cognitive function), severity of post-traumatic stress disorder, general health, and adverse events.</AbstractText><AbstractText Label="RESULTS">Between January 2021 and July 2022, 39&#x2009;697 people were invited to take part in the study and 725 were contacted and eligible. 585 participants were randomised. Mean age was 56 (standard deviation (SD) 12) years, 52% were female participants, mean health related quality of life PROMIS-PROPr score was 0.20 (SD 0.17), and mean time from hospital discharge was 323 (SD 144) days. Compared with usual care, the REGAIN intervention led to improvements in health related quality of life (adjusted mean difference in PROPr score 0.03 (95% confidence interval 0.01 to 0.05), P=0.02) at three months, driven predominantly by greater improvements in the PROMIS subscores for depression (1.39 (0.06 to 2.71), P=0.04), fatigue (2.50 (1.19 to 3.81), P&lt;0.001), and pain interference (1.80 (0.50 to 3.11), P=0.01). Effects were sustained at 12 months (0.03 (0.01 to 0.06), P=0.02). Of 21 serious adverse events, only one was possibly related to the REGAIN intervention. In the intervention group, 141 (47%) participants fully adhered to the programme, 117 (39%) partially adhered, and 40 (13%) did not receive the intervention.</AbstractText><AbstractText Label="CONCLUSIONS">In adults with post-covid-19 condition, an online, home based, supervised, group physical and mental health rehabilitation programme was clinically effective at improving health related quality of life at three and 12 months compared with usual care.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ISRCTN registry ISRCTN11466448.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McGregor</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8963-9107</Identifier><AffiliationInfo><Affiliation>University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>Harbinder</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheehan</LastName><ForeName>Bartholomew</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Oxford Psychological Medicine Centre, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McWilliams</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Care Excellence, University Hospitals Coventry and Warwickshire NHS Trust and Coventry University, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Joyce</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ICUsteps, Kemp House, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alleyne</LastName><ForeName>Sharisse</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lall</LastName><ForeName>Ranjit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratna</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ennis</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heine</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Shilpa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Psychology, Deakin University, Geelong, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwankwo</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Vivien</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seers</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Underwood</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2024 Feb 7;384:q20. doi: 10.1136/bmj.q20</RefSource><PMID Version="1">38325886</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>BMJ. 2024 May 1;385:q988. doi: 10.1136/bmj.q988</RefSource><PMID Version="1">38692662</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067250" MajorTopicYN="Y">Psychiatric Rehabilitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. GM, MU, JB, HS, KS, and JY are chief investigators or co-investigators on multiple previous and current research grants from the UK National Institute for Health and Care Research. GM and SE are directors of Atrium Health, a non-profit cardiopulmonary rehabilitation provider, which provided the treatment hub for the Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) trial. Both receive payment for their work as directors. HS and SP are directors of Health Psychology Services, a private health psychology provider. DM is a physiotherapist delivering post-intensive care unit rehabilitation for the NHS. MU is a current or recent co-investigator on Arthritis Research UK, Australian National Health and Medical Research Council, and Norwegian Medical Research Council grants; a director and shareholder of Clinvivo, which provides electronic data collection for health services research; part of an academic partnership with Serco, funded by the European Social Fund, related to return-to-work initiatives, and a co-investigator on two current and one recent National Institute for Health and Care Research (NIHR) funded studies receiving additional support from Stryker. JB has received travel expenses for speaking at conferences from the professional organisations hosting these conferences. JY is an existing member of the NIHR Health Technology Assessment General Funding Committee. KS was a member of the NIHR Health and Social Care Delivery Research Board from 2010 to 2018.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38325873</ArticleId><ArticleId IdType="pmc">PMC11134408</ArticleId><ArticleId IdType="doi">10.1136/bmj-2023-076506</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Institute for Health Metrics and Evaluation. At least 17 million people in the WHO European Region experienced long COVID in the first two years of the pandemic; millions may have to live with it for years to come. https://www.healthdata.org/news-release/who-least-17-million-people-who-european-region-experienced-long-covid-first-two-years. World Health Organization (WHO); 2022.</Citation></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30 March 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023: ONS website, statistical bulletin; 2023.</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21:133-46. 10.1038/s41579-022-00846-2&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Tabassum D, Baig SS, et al. . Effect of Exercise Interventions on Health-Related Quality of Life After Stroke and Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke 2021;52:2445-55. 10.1161/STROKEAHA.120.032979&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032979</ArticleId><ArticleId IdType="pubmed">34039033</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizinga F, Westerink NL, Berendsen AJ, et al. . Home-based Physical Activity to Alleviate Fatigue in Cancer Survivors: A Systematic Review and Meta-analysis. Med Sci Sports Exerc 2021;53:2661-74. 10.1249/MSS.0000000000002735&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000002735</ArticleId><ArticleId IdType="pmc">PMC8594505</ArticleId><ArticleId IdType="pubmed">34649267</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;2015:CD003793. 10.1002/14651858.CD003793.pub3&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003793.pub3</ArticleId><ArticleId IdType="pmc">PMC10008021</ArticleId><ArticleId IdType="pubmed">25705944</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor G, Sandhu H, Bruce J, et al. . Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN&#x2032; (REGAIN): a structured summary of a study protocol for a randomised controlled trial. Trials 2021;22:8. 10.1186/s13063-020-04978-9&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04978-9</ArticleId><ArticleId IdType="pmc">PMC7785779</ArticleId><ArticleId IdType="pubmed">33407804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ennis S, Heine P, Sandhu H, et al. . Development of an online intervention for the Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) trial. NIHR Open Res 2023;3:10. 10.3310/nihropenres.13371.2&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/nihropenres.13371.2</ArticleId><ArticleId IdType="pmc">PMC10593321</ArticleId><ArticleId IdType="pubmed">37881468</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhon DI, Fritz JM, Kerns RD, et al. . TIDieR-telehealth: precision in reporting of telehealth interventions used in clinical trials - unique considerations for the Template for the Intervention Description and Replication (TIDieR) checklist. BMC Med Res Methodol 2022;22:161. 10.1186/s12874-022-01640-7&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01640-7</ArticleId><ArticleId IdType="pmc">PMC9161193</ArticleId><ArticleId IdType="pubmed">35655144</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 3 March 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3march2022: ONS website, statistical bulletin; 2022.</Citation></Reference><Reference><Citation>NHS England. Your COVID Recovery. https://www.yourcovidrecovery.nhs.uk; 2021.</Citation></Reference><Reference><Citation>Dewitt B, Jalal H, Hanmer J. Computing PROPr Utility Scores for PROMIS&#xae; Profile Instruments. Value Health 2020;23:370-8. 10.1016/j.jval.2019.09.2752&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2019.09.2752</ArticleId><ArticleId IdType="pmc">PMC7269185</ArticleId><ArticleId IdType="pubmed">32197733</ArticleId></ArticleIdList></Reference><Reference><Citation>WordPress. The PROMIS-Preference Score. What is this minimally important difference for PROPr? https://www.proprscore.com/faqs/; 2023.</Citation></Reference><Reference><Citation>Terwee CB, Peipert JD, Chapman R, et al. . Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual Life Res 2021;30:2729-54. 10.1007/s11136-021-02925-y&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02925-y</ArticleId><ArticleId IdType="pmc">PMC8481206</ArticleId><ArticleId IdType="pubmed">34247326</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727-36. 10.1007/s11136-011-9903-x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>IPAQ. Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ) &#x2013; Short and Long Forms. https://www.physio-pedia.com/images/c/c7/Quidelines_for_interpreting_the_IPAQ.pdf; 2005.</Citation></Reference><Reference><Citation>Weiss D, Marmar C. Assessing psychological trauma and PTSD - The Impact of Event Scale-Revised. The Guilford Press, 1997.</Citation></Reference><Reference><Citation>Somaini G, Hasler ED, Saxer S, et al. . Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy. Respiration 2016;91:359-66. 10.1159/000445805&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000445805</ArticleId><ArticleId IdType="pubmed">27189373</ArticleId></ArticleIdList></Reference><Reference><Citation>International Council for Harmonisation. Integrated addendum to ICH E6 (R1): guideline for good clinical practice. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf; 2016.</Citation></Reference><Reference><Citation>Stussman B, Williams A, Snow J, et al. . Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Neurol 2020;11:1025. 10.3389/fneur.2020.01025&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01025</ArticleId><ArticleId IdType="pmc">PMC7530890</ArticleId><ArticleId IdType="pubmed">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med 2008;27:2850-64. 10.1002/sim.3115&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3115</ArticleId><ArticleId IdType="pubmed">17960589</ArticleId></ArticleIdList></Reference><Reference><Citation>Warwick Clinical Trials Unit. REGAIN: Statistical Analysis Plan. https://warwick.ac.uk/fac/sci/med/research/ctu/trials/regain/analysisplans/; 2022.</Citation></Reference><Reference><Citation>Roberts C, Roberts SA. Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials 2005;2:152-62. 10.1191/1740774505cn076oa&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1740774505cn076oa</ArticleId><ArticleId IdType="pubmed">16279137</ArticleId></ArticleIdList></Reference><Reference><Citation>White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30:377-99. 10.1002/sim.4067&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4067</ArticleId><ArticleId IdType="pubmed">21225900</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Social Care. UK Chief Medical Officers&#x2019; Physical Activity Guidelines. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/832868/uk-chief-medical-officers-physical-activity-guidelines.pdf: NHS England, HM Government: Crown Copyright; 2019.</Citation></Reference><Reference><Citation>Tran V-T, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun 2022;13:1812. 10.1038/s41467-022-29513-z&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis LL, Schein J, Cloutier M, et al. . The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective. J Clin Psychiatry 2022;83:21m14116. 10.4088/JCP.21m14116&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.21m14116</ArticleId><ArticleId IdType="pubmed">35485933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg L, Garrod R, Thornton H, McDonnell L, Bellas H, White P. Effectiveness, attendance, and completion of an integrated, system-wide pulmonary rehabilitation service for COPD: prospective observational study. COPD 2012;9:546-54. 10.3109/15412555.2012.707258&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2012.707258</ArticleId><ArticleId IdType="pubmed">23030586</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin B-J, Hauer T, Arena R, et al. . Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation 2012;126:677-87. 10.1161/CIRCULATIONAHA.111.066738&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.066738</ArticleId><ArticleId IdType="pubmed">22777176</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians. National COPD Audit Programme: Pulmonary Rehabilitation: Steps to breathe better. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Clinical audit of Pulmonary Rehabilitation services in England and Wales 2015. https://www.rcplondon.ac.uk/projects/outputs/pulmonary-rehabilitation-steps-breathe-better; 2016.</Citation></Reference><Reference><Citation>Hansen NB, Lambert MJ, Forman EM. The psychotherapy dose-response effect and its implications for treatment delivery services. Clin Psychol (New York) 2002;9:329-43 10.1093/clipsy.9.3.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clipsy.9.3.329</ArticleId></ArticleIdList></Reference><Reference><Citation>Borek AJ, Abraham C. How do Small Groups Promote Behaviour Change? An Integrative Conceptual Review of Explanatory Mechanisms. Appl Psychol Health Well Being 2018;10:30-61. 10.1111/aphw.12120&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aphw.12120</ArticleId><ArticleId IdType="pubmed">29446250</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardi I, Goessler K, de Oliveira J&#xfa;nior GN, et al. . Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19: a randomised controlled trial. Br J Sports Med 2023;57:1295-303. 10.1136/bjsports-2022-106681&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2022-106681</ArticleId><ArticleId IdType="pubmed">37164620</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentschot JC, Heijenbrok-Kal MH, Bek LM, et al. CO-FLOW Collaboration Group . Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: A multicenter prospective cohort study (CO-FLOW). Lancet Reg Health Eur 2022;22:100485. 10.1016/j.lanepe.2022.100485&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9402257</ArticleId><ArticleId IdType="pubmed">36039177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen JR, Sari DM, Juhl CB, et al. . Variability in effect sizes of exercise therapy for knee osteoarthritis depending on comparator interventions. Ann Phys Rehabil Med 2023;66:101708. 10.1016/j.rehab.2022.101708&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2022.101708</ArticleId><ArticleId IdType="pubmed">36191859</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS England. Covid-19 &#x2013; Notice under Regulation 3(4) of the Health Service Control of Patient Information Regulations 2002. https://digital.nhs.uk/coronavirus/coronavirus-covid-19-response-information-governance-hub/control-of-patient-information-copi-notice#download-the-copi-notice: NHS England, HM Government: Crown Copyright; 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>